
Catch up on the top radiology content of the past week.
Catch up on the most-well viewed prostate imaging content in September 2024.
Touching on a variety of topics in prostate cancer imaging, ranging from Phase 3 trial results for 177Lu-PSMA-617 in taxane-naïve patients with mCRPC to a new meta-analysis comparing PSMA PET/CT to mpMRI in detecting biomechanical recurrence of PCa, here are the top five most well-viewed prostate imaging content from Diagnostic Imaging for September 2024.


